Evaluation of umbilical cord blood hematological parameters in pregnant women with fetal growth restriction

Abstract

Objectives: The present study attempted to evaluate the relationship between fetal growth restriction (FGR) and the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) in singleton term pregnancy.

Methods: We carried out this prospective, case-control study at a Training and Research Hospital in Türkiye between May 2021 and January 2023. We utilized ultrasonography to assess singleton pregnancy with FGR between 37-40 weeks of gestation and considered the patients’ last menstrual periods (LMD).

Results: We recruited 250 pregnant women in the study and divided them into the FGR (n = 125) and healthy control (n = 125) groups. Our findings revealed no significant difference between the groups by age, body mass index (BMI), stillbirth history, abortion, tobacco use, and regular pregnancy monitoring (p > 0.05). Fetal birth weights and hospitalization in the neonatal intensive care unit (NICU) were also similar between the groups. Yet, 1- and 5-minute APGAR scores were significantly lower in the FGR group than in the control group. In addition, compared to the healthy subjects, the FGR group had significantly increased white blood cell, lymphocyte, neutrophil, platelet counts and NLR and PLR values, but mean platelet volume (MPV) remained similar.

Conclusions: In a nutshell, our findings suggested that two noteworthy inflammatory markers, NLR and PLR, are likely to elevate in the presence of FGR.

Keywords

• Fetal growth restriction
• neutrophil-to-lymphocyte ratio (NLR)
• platelet-to-lymphocyte ratio (PLR)
• hematologic parameters
• cord blood

References

1. 1. Colella M, Frérot A, Novais AR, Baud, O. Neonatal and long-term consequences of fetal growth restriction. Curr Pediatr Rev 2018;14:212-8.
2. 2. Haragan AF, Hulsey TC, Hawk AF, Newman RB, Chang EY. Diagnostic accuracy of fundal height and handheld ultrasound-measured abdominal circumference to screen for fetal growth abnormalities. Am J Obstet Gynecol 2015;212:820.e1-8.
3. 3. Morley LC, Debant M, Walker JJ, Beech DJ, Simpson NAB. Placental blood flow sensing and regulation in fetal growth restriction. Placenta 2021;113:23-8.
4. 4. Eraslan Sahin M, Sahin E, Col Madendag I, Madendag Y, Acmaz G, Ozdemir F, et al. Evaluation of mid-trimester ductus venosus diameter and peak systolic velocity to predict late onset small for gestational age fetuses. J Matern Fetal Neonatal Med 2022;35:3984-90.
5. 5. llsley NP, DaSilva-Arnold SC, Zamudio S, Alvarez M, Al-Khan A. Trophoblast invasion: Lessons from abnormally invasive placenta (placenta accreta). Placenta 2020;102:61-6.
6. 6. Ortega MA, Fraile-Martínez O, García-Montero C, Sáez MA, Álvarez-Mon MA, Torres-Carranza D, De León-Luis JA. The pivotal role of the placenta in normal and pathological pregnancies: a focus on preeclampsia, fetal growth restriction, and maternal chronic venous disease. Cells 2022;11:568.
7. 7. Neumann S, Krause SW, Maschmeyer G, Schiel X, von Lilienfeld-Toal M. Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2013;92:433-42.
8. 8. Kale İ, Helvacıoğlu Ç, Muğurtay TE. Evaluation of complete blood count parameters in the first trimester: an early indicator of miscarriage. J Clin Invest Surg 2021;6: 48-52.

9. 9. Kang Q, Li W, Yu N, Fan L, Zhang Y, Sha M, et al. Predictive role of neutrophil-to-lymphocyte ratio in preeclampsia: A meta-analysis including 3 982 patients. Pregnancy Hypertens 2020;20:111-8.
10. 10. Liu W, Lou X, Zhang Z, Chai Y, Yu, Q. Association of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, mean platelet volume with the risk of gestational diabetes mellitus. Gynecol Endocrinol 2021;37:105-7.
11. 11. Gordijn S, Beune I, Thilaganathan B, Papageorghiou A, Baschat A, Baker P, et al. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol 2016;48:333-9.
12. 12. Kirlangic MM, Sahin E, Madendag Y, Vural Yalman M, Akdemir E, Eraslan Sahin M, et al. The role of the brain-sparing effect of growth-restricted fetuses in newborn germinal matrix/intraventricular hemorrhage. J Perinat Med 2022;50:93-9.
13. 13. Melamed N, Baschat A, Yinon Y, Athanasiadis A, Mecacci F, Figueras, et al. FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction. Int J Gynaecol Obstet 2021;152(Suppl 1):3-57.
14. 14.Lindqvist PG, Molin J. Does antenatal identification of small-for-gestational age fetuses significantly improve their outcome? Ultrasound Obstet Gynecol 2005;25:258-64.
15. 15. Rogers LK, Velten M. Maternal inflammation, growth retardation, and preterm birth: insights into adult cardiovascular disease. Life Sci 2011;89:417-21.
16. 16. Toptas M, Asik H, Kalyoncuoglu M, Can E, Can MM. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio predictors for severity of preeclampsia? J Clin Gynecol Obstet 2016;5:27-31.
17. 17. Lelic M, Bogdanovic G, Ramic S, Brkicevic E. Influence of maternal anemia during pregnancy on placenta and newborns. Med Arch 2014;68:184-7.
18. 18. Kozuki N, Lee AC, Katz J. Moderate to severe, but not mild, maternal anemia is associated with increased risk of small-for-gestational-age outcomes. J Nutr 2012;142:358-62.
19. 19. Lurie S, Mamet Y. Red blood cell survival and kinetics during pregnancy. Eur J Obstet Gynecol Reprod Biol 2000;93:185-92.
20. 20. Guven MA, Coskun A, Ertas IE, Aral M, Zencırcı B, Oksuz H. Association of maternal serum CRP, IL-6, TNF-α, homocysteine, folic acid and vitamin b12 levels with the severity of preeclampsia and fetal birth weight. Hypertens Pregn 2009;28:190-200.
21. 21. lo K, Blix ES, Husebekk A, Thommessen A, Uhre AT, Wilsgaard T, et al. A longitudinal study of maternal endothelial function, inflammatory response and uterine artery blood flow during the second half of pregnancy. Acta Obstetr Gynecol Scand 2016;95:225-32.
22. 22. Yang SW, Cho SH, Kwon HS, Sohn IS, Hwang HS. Significance of the platelet distribution width as a severity marker for the development of preeclampsia. Eur J Obstet Gynecol Reprod Biol 2014;175:107-11.
23. 23. Aytan P, Babuş SB, Sakarya Ö, Çiftçi RS, Kasım AK, et al. Comparison of the progressive changes in hemogram parameters of normal glycemic and gestational diabetic patients throughout the first two trimesters and predictive ability of these indices for gestational diabetes mellitus. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi 2020;17:533-7.
24. 24. Soysal C, Işıkalan MM, Bıyık İ, Erten Ö, İnce O. The relationship between inflammation markers and ketonuria in hyperemesis gravidarum. J Obstet Gynaecol Res 2021;47:3078-83.
25. 25. Akkaya H, Uysal G. Can hematologic parameters predict treatment of ectopic pregnancy? Pak J Med Sci 2017;33:937-42.
26. 26. Bullens LM, Smith JS, Truijens SEM, van der Hout-van der Jagt MB, van Runnard Heimel PJ, Oei SG. Maternal hemoglobin level and its relation to fetal distress, mode of delivery, and short-term neonatal outcome: a retrospective cohort study. J Matern Fetal Neonatal Med 2020;33:3418-24.
27. 27. Kırlangıç MM, Sade OS, Yalman MV, Akdemir E. Evaluation of third-trimester neutrophil-lymphocyte and platelet-lymphocyte ratios and their correlation with birth weight. Age 2021;29:18-43.